
FDA expected to fast-track approval of J&J experimental COVID-19 vaccine for emergency use authorization
Johnson & Johnson submitted an application on Thursday to the Food and Drug Administration for an emergency use authorization of its experimental Covid-19 vaccine. The FDA could grant that authorization within weeks; if authorized, it would give